Table 1 miR-363 expression and clinicopathological features in 49 osteosarcoma
Clinicopathological features | Cases (n = 49) | miR-363 expression | P value* | |
|---|---|---|---|---|
23 high (%) | 26 low (%) | |||
Gender | ||||
Male | 25 | 12 (48.0) | 13 (52.0) | 0.879 |
Female | 24 | 11 (45.8) | 13 (51.2) | |
Age (years) | ||||
≤ 18 | 21 | 13 (61.9) | 8 (38.1) | 0.124 |
> 18 | 28 | 10 (35.7) | 18 (64.3) | |
Tumor size (mm) | ||||
≤ 5.0 | 22 | 14 (63.6) | 8 (36.4) | 0.035* |
> 5.0 | 27 | 9 (33.3) | 18 (66.7) | |
TNM stage | ||||
I–II | 24 | 15 (62.5) | 9 (37.5) | 0.032* |
III–IV | 25 | 8 (32.0) | 17 (68.0) | |
Lymph node metastasis | ||||
0–2 | 28 | 17 (60.7) | 11 (39.3) | 0.026* |
> 2 | 21 | 6 (28.6) | 15 (71.4) | |
Metastasis | ||||
Absent | 23 | 14 (60.9) | 9 (39.1) | 0.066 |
Present | 26 | 9 (34.6) | 17 (65.4) | |
NOB1 | ||||
Low expression | 23 | 8 (34.8) | 15 (65.2) | 0.011* |
High expression | 26 | 15 (57.7) | 11 (42.3) | |